C5a



C5a

N1NN1L2LL2H3HH3L4LL4L5LL5R6RR6Q7QQ7K8KK8I9II9E10EE10E11EE11Q12QQ12A13AA13A14AA14K15KK15Y16YY16K17KK17H18HH18S19SS19V20VV20P21PP21K22KK22K23KK23C24CC24C25CC25Y26YY26D27DD27G28GG28A29AA29R30RR30V31VV31N32NN32F33FF33Y34YY34E35EE35T36TT36C37CC37E38EE38E39EE39R40RR40V41VV41A42AA42R43RR43V44VV44T45TT45I46II46G47GG47... and 30 more residue(s)...... and 30 more residue(s)

SMILES None
InChIKey None
Sequence NLHLLRQKIEEQAAKYKHSVPKKCCYDGARVNFYETCEERVARVTIGPLCIRAFNECCTIANKIRKESPHKPVQLGR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

C5a

N1NN1L2LL2H3HH3L4LL4L5LL5R6RR6Q7QQ7K8KK8I9II9E10EE10E11EE11Q12QQ12A13AA13A14AA14K15KK15Y16YY16K17KK17H18HH18S19SS19V20VV20P21PP21K22KK22K23KK23C24CC24C25CC25Y26YY26D27DD27G28GG28A29AA29R30RR30V31VV31N32NN32F33FF33Y34YY34E35EE35T36TT36C37CC37E38EE38E39EE39R40RR40V41VV41A42AA42R43RR43V44VV44T45TT45I46II46G47GG47... and 30 more residue(s)...... and 30 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.